What is AEON Biopharma, Inc. (AEON) stock price today?

AEON Biopharma, Inc. (AEON) is currently trading at $0.28, down 10.97% today.

What is AEON P/E ratio?

AEON Biopharma, Inc.'s P/E ratio is -0.08. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AEON return on equity (ROE)?

AEON Biopharma, Inc.'s return on equity (ROE) is 204.18%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is AEON Biopharma, Inc.'s market cap?

AEON Biopharma, Inc. has a market capitalization of $12.19M.

AMEX · Biotechnology

AEON Biopharma, Inc. (AEON) Stock

$0.28 -10.97% AMEX: AEON Healthcare

Valuation

Metric	Value
Price	$0.28
Market Cap	$12.19M
P/E Ratio	-0.08
P/B Ratio	-1.02
P/S Ratio	0.00
EPS (TTM)	$-3.95
52-Week High	$1.45
52-Week Low	$0.18
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	204.18%
ROA	-924.25%
ROCE	1300.00%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.18
Current Ratio	0.43

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-66.0M	$-48.0M	$-348.0M	$73.0M	$-13.0M
Net Profit	$-56.0M	$-53.0M	$-385.0M	$42.0M	$-39.0M
EPS	$18.86	$-27.25	$-744.83	$72.93	$-3.95
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$6.0M	$11.0M	$7.0M	$3.0M	$6.0M
Total Liabilities	$230.0M	$281.0M	$160.0M	$32.0M	$61.0M
Cash	$5.0M	$10.0M	$5.0M	$0	$3.0M
Borrowings	$87.0M	$132.0M	$0	$13.0M	$36.0M

Latest News

Aeon Biopharma Prices $13.8 Million Underwritten Public Offering MT Newswires · Jul 14, 2026 AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding GlobeNewswire · Jul 14, 2026 AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society GlobeNewswire · Jun 4, 2026 Cervical Dystonia Market to Witness Robust Growth During the Forecast Period (2026-2036) Driven by the Expanding Therapeutic Options | DelveInsight PR Newswire · Jun 2, 2026 Why You Might Be Interested In Aeon Co. (M) Bhd. (KLSE:AEON) For Its Upcoming Dividend Simply Wall St. · May 25, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-28.0M	$-36.0M	$-48.0M	$-20.0M	$-17.0M
Investing Cash Flow	$0	$-1.0M	$0	$0	$0
Financing Cash Flow	$-1.0M	$0	$0	$0	$2.0M
Net Cash Flow	$-15.0M	$5.0M	$-5.0M	$-5.0M	$3.0M
Free Cash Flow	$-29.0M	$-36.0M	$-48.0M	$-20.0M	$-17.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.51
FCF Yield	-99.25%
Quick Ratio	0.54
Interest Coverage	0.00
Return 1Y	-62.49%
Return 3Y	-99.95%
Return 5Y	—

Ownership

Insiders Held45.68%

Institutions Held3.25%

Institutions Float Held5.98%

Institutional Holder	Shares	Report Date
Dauntless Investment Group, LLC	2,527,775	2026-03-31
Vanguard Capital Management LLC	90,529	2026-03-31
Geode Capital Management, LLC	87,062	2026-03-31
Blue Owl Capital Holdings LP	42,353	2026-03-31
Xtx Topco Ltd	20,424	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ABPAbpro Corporation	$0.52	—	-0.02	$1.06M	0.00%
APM	$0.81	-0.78%	-4.42	$5.15M	0.00%
BOLTBolt Biotherapeutics, Inc.	$4.11	+12.60%	-0.22	$7.90M	0.00%
CINGCingulate Inc.	$4.89	+0.20%	-0.95	$65.86M	0.00%
CLNNClene Inc.	$3.86	-0.52%	-1.10	$49.32M	0.00%

About AEON Biopharma, Inc.

AEON Biopharma, Inc. is led by CEO Robert Bancroft, employs 5 people, headquartered in US, publicly traded since 2023.

AEON Biopharma, Inc. (AEON) stock trades at $0.28 with a market capitalization of $12.19M. The stock is valued at a price-to-earnings (P/E) ratio of -0.08, price-to-book of -1.02, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.18 and $1.45, and currently trades 80.7% below its 52-week high.

On profitability, AEON Biopharma, Inc. generates a return on equity (ROE) of 204.18% — well above the market average, a sign of a high-quality business, return on capital employed of 1300.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides